BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11448648)

  • 21. Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender.
    Heagerty A; Smith A; English J; Lear J; Perkins W; Bowers B; Jones P; Gilford J; Alldersea J; Fryer A; Strange RC
    Br J Cancer; 1996 Jan; 73(1):44-8. PubMed ID: 8554981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC->AT transition mutations in a population exposed to methylating agents.
    Lees NP; Harrison KL; Hall CN; Margison GP; Povey AC
    Carcinogenesis; 2004 Jul; 25(7):1243-7. PubMed ID: 14963016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topographical study of O(6)-alkylguanine DNA alkyltransferase repair activity and N7-methylguanine levels in resected lung tissue.
    Crosbie PA; Harrison K; Shah R; Watson AJ; Agius R; Barber PV; Margison GP; Povey AC
    Chem Biol Interact; 2013 Jul; 204(2):98-104. PubMed ID: 23665414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
    Maynard K; Parsons PG; Cerny T; Margison GP
    Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-6-alkylguanine-DNA alkyltransferase activity in tissues of mice treated with antischistosomal agents.
    Badawi A
    Oncol Rep; 1994 Sep; 1(5):1023-7. PubMed ID: 21607486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between tissue-specific DNA alkylation, DNA repair and cell proliferation in the colon and colon tumour yield in mice treated with 1,2-dimethylhydrazine.
    Jackson PE; O'Connor PJ; Cooper DP; Margison GP; Povey AC
    Carcinogenesis; 2003 Mar; 24(3):527-33. PubMed ID: 12663514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between smoking, GST genotypes and N7-methylguanine levels in DNA extracted from bronchial lavage cells.
    Lewis SJ; Cherry NM; Niven RM; Barber PV; Povey AC
    Mutat Res; 2004 Apr; 559(1-2):11-8. PubMed ID: 15066569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1 CYP2D6 and GSTM1 genetic polymorphisms.
    Butkiewicz D; Grzybowska E; Hemminki K; Ovrebø S; Haugen A; Motykiewicz G; Chorazy M
    Mutat Res; 1998 Jul; 415(1-2):97-108. PubMed ID: 9711266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours.
    Clemons MJ; Bibby MC; El Teraifi H; Forster G; Kelly J; Banerjee S; Cadman B; Ryder WD; Howell A; Margison GP
    Br J Cancer; 2002 Jun; 86(11):1797-802. PubMed ID: 12087469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients.
    Anwar WA; Abdel-Rahman SZ; El-Zein RA; Mostafa HM; Au WW
    Carcinogenesis; 1996 Sep; 17(9):1923-9. PubMed ID: 8824515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of CYP2D6, GSTM1, and GSTT1 genes and bladder cancer risk in North India.
    Sobti RC; Al-Badran AI; Sharma S; Sharma SK; Krishan A; Mohan H
    Cancer Genet Cytogenet; 2005 Jan; 156(1):68-73. PubMed ID: 15588859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma].
    Zhu Y; Deng C; Zhang Y; Zhou X; He X
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):538-40. PubMed ID: 12421502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.
    Gertig DM; Stampfer M; Haiman C; Hennekens CH; Kelsey K; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):1001-5. PubMed ID: 9829708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp.
    Perrett CW; Clayton RN; Pistorello M; Boscaro M; Scanarini M; Bates AS; Buckley N; Jones P; Fryer AA; Gilford J
    Carcinogenesis; 1995 Jul; 16(7):1643-5. PubMed ID: 7614700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility and outcome in oral cancer: preliminary data showing an association with polymorphism in cytochrome P450 CYP2D6.
    Worrall SF; Corrigan M; High A; Starr D; Matthias C; Wolf CR; Jones PW; Hand P; Gilford J; Farrell WE; Hoban P; Fryer AA; Strange RC
    Pharmacogenetics; 1998 Oct; 8(5):433-9. PubMed ID: 9825835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
    Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
    BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variability and regulation of O6-alkylguanine-DNA alkyltransferase.
    Margison GP; Povey AC; Kaina B; Santibáñez Koref MF
    Carcinogenesis; 2003 Apr; 24(4):625-35. PubMed ID: 12727789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic genotypes and risk for colorectal cancer.
    Butler WJ; Ryan P; Roberts-Thomson IC
    J Gastroenterol Hepatol; 2001 Jun; 16(6):631-5. PubMed ID: 11422615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo.
    Kato S; Bowman ED; Harrington AM; Blomeke B; Shields PG
    J Natl Cancer Inst; 1995 Jun; 87(12):902-7. PubMed ID: 7666479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylation tolerance due to an O6-methylguanine DNA methyltransferase (MGMT) field defect in the colonic mucosa: an initiating step in the development of mismatch repair-deficient colorectal cancers.
    Svrcek M; Buhard O; Colas C; Coulet F; Dumont S; Massaoudi I; Lamri A; Hamelin R; Cosnes J; Oliveira C; Seruca R; Gaub MP; Legrain M; Collura A; Lascols O; Tiret E; Fléjou JF; Duval A
    Gut; 2010 Nov; 59(11):1516-26. PubMed ID: 20947886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.